Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxercalciferol Effect on Endothelial Function in ESRD
NCT00528788Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2007
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxercalciferol in secondary hyperparathyroidism (SHPT), sponsored by Duke University. Started Sep 2007; status: completed.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00528788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528788.